We have tabulated and graphed key clinical trial results that support the use of standard of care therapies for ovarian cancer, as well as ongoing trials into new investigational agents. To find outcomes and status for completed and on-going trials, please select your preferred way to search.
Find results based on your patient’s clinical situation (e.g., platinum-sensitive recurrent disease).
Find results by drug name (e.g., Olaparib) or drug class (e.g., PARP inhibitors)
About the Data Displayed On These Pages
NCCN and NCI guidelines were used to select trials to illustrate the effectiveness of standard chemotherapies. Phase II and III results for trials of investigational drugs are displayed if the drugs are still being developed. Phase I results are displayed if at least 16 ovarian cancer patients participated in the trial.
Note that comparison of the specific results in one clinical trial to those of another should be performed with caution because patient disease characteristics can vary from one trial to another.
To our knowledge, we have accurately represented the information shown, but this data should be independently verified.